title: Experimental treatment of bupivacaine cardiotoxicity: what is the best choice?
authors.forename: J E
authors.initials: JE
authors.lastname: de La Coussaye
authors.forename: B P
authors.initials: BP
authors.lastname: Bassoul
authors.forename: J P
authors.initials: JP
authors.lastname: Gagnol
authors.forename: A
authors.initials: A
authors.lastname: Sassine
authors.forename: J J
authors.initials: JJ
authors.lastname: Eledjam
mesh_terms: D000638:Amiodarone / Q000627:therapeutic use*; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced* / Q000188:drug therapy; D001949:Bretylium Compounds / Q000627:therapeutic use*; D002045:Bupivacaine / Q000009:adverse effects* / Q000037:antagonists & inhibitors / Q000633:toxicity; D006801:Humans
chemical_list: D001949:Bretylium Compounds; D000638:Amiodarone; C045166:bretylium; D002045:Bupivacaine